-
Signature
-
/s/ Bruce Blefeld, Attorney-in-Fact
-
Stock symbol
-
ZLAB
-
Transactions as of
-
Apr 3, 2024
-
Transactions value $
-
$50,801
-
Form type
-
4
-
Date filed
-
4/5/2024, 05:48 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ZLAB |
American Depositary Shares |
Options Exercise |
$83.8K |
+5.27K |
+10.84% |
$15.90 |
53.9K |
Apr 3, 2024 |
Direct |
F1, F2 |
transaction |
ZLAB |
American Depositary Shares |
Sale |
-$33K |
-2.11K |
-3.91% |
$15.67 |
51.8K |
Apr 4, 2024 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ZLAB |
Restricted Share Units |
Options Exercise |
$0 |
-5.27K |
-25% |
$0.00 |
15.8K |
Apr 3, 2024 |
American Depositary Shares |
5.27K |
|
Direct |
F1, F4, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases